Neurofix

Lipid-based therapies for the treatment of neuropathic pain

OWNER

Maria Sola Gil (See Profile)


Sector

Biotech

Stage

Development, market readiness, clinical trial

Country

Spain


Patented technology in major global countries

Maximisation of Asset with evaluation of additional indications

Finalisation of recruitment of Phase IIA. First efficacy results available in Q1 2022.

Orphan Drug for Indication Neuropathic Pain in Spinal Cord Injury

Drug targets an unmet need

Status

Approved

IP Type

Patent

Time

8 years

Countries

Australia
Austria
Belgium
Canada
China
Denmark
Finland
France
Germany
Israel
Italy
Japan
Netherlands
Russia
South Korea
Spain
Switzerland
USA
United Kingdom

Coverage

ALPHA-DERIVATIVES OF CIS-MONOUNSATURATED FATTY ACIDS INTENDED FOR USE AS A DRUG

The invention relates to alpha-derivatives of cis-monounsaturated fatty acids intended for use as a drug. More specifically, the invention relates to compounds having formula I, and the pharmaceutically acceptable derivatives and salts thereof, in which (a) and (b) can have any value between 0 and 14, (X) can be substituted by any atom or group of atoms with a weight between 4 and 200 Da, and (R) can be substituted by any atom or group of atoms with a weight between 1 and 200 Da, intended for use as a drug.

Know more of this patent

This information is confidential, do not share or copy.

Under evaluation at least till: 9th of December

If you want to have more information or you want to review the project, you have to login or register

KEEP REVIEWING

©2021 BioExpert Network

About cookies

This website uses cookies to give you the best user experience. If you continue browsing you are giving your consent for the acceptance of those cookies and the acceptance of our cookies policy.

If you continue to browse and use this website you are agreeing to comply with and be bound by the following Terms of Use

ACEPTAR
Aviso de cookies

Log in with your credentials

or    

Forgot your details?

Create Account

Skip to toolbar